Highlights and Quick Summary
- Non-operating Income/Expense for the quarter ending September 30, 2023 was $3.8 Million (a 59.91% increase compared to previous quarter)
- Year-over-year quarterly Non-operating Income/Expense decreased by -585.44%
- Annual Non-operating Income/Expense for 2022 was $-6.23 Million (a -107.72% decrease from previous year)
- Annual Non-operating Income/Expense for 2021 was $80.6 Million (a 256.78% increase from previous year)
- Annual Non-operating Income/Expense for 2020 was $22.6 Million (a 6301.42% increase from previous year)
- Twelve month Non-operating Income/Expense ending September 30, 2023 was $9.23 Million (a 16.16% increase compared to previous quarter)
- Twelve month trailing Non-operating Income/Expense decreased by -248.29% year-over-year
Trailing Non-operating Income/Expense for the last four month:
| 30 Sep '23 | 30 Jun '23 | 31 Mar '23 | 31 Dec '22 |
|---|---|---|---|
| $9.23 Million | $7.95 Million | $2.09 Million | $-6.23 Million |
Visit stockrow.com/PRME
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Non-operating Income/Expense of Prime Medicine, Inc.
Most recent Non-operating Income/Expenseof PRME including historical data for past 10 years.Interactive Chart of Non-operating Income/Expense of Prime Medicine, Inc.
Prime Medicine, Inc. Non-operating Income/Expense for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $3.8 | $2.38 | $3.84 | – | – |
| 2022 | $-0.78 | $2.52 | $-3.49 | $-4.47 | $-6.23 |
| 2021 | – | – | – | $-8.36 | $80.62 |
| 2020 | – | – | – | – | $22.6 |
| 2019 | – | – | – | – | $0.35 |
Business Profile of Prime Medicine, Inc.
Sector: Healthcare
Industry: Biotechnology